| Literature DB >> 36050432 |
Hyun Mi Kim1, Hyun-Hwa Cha1, Won Joon Seong1, Hye Jin Lee1, Mi Ju Kim2.
Abstract
This study aimed to determine the relationship between estimated fetal weight discordance by ultrasonography and maternal and neonatal outcomes in dichorionic diamniotic twin pregnancies. We conducted a retrospective review of the medical records of 106 twin pregnancies delivered at a single tertiary center between January 2011 and February 2020. At 20-24 and 28-32 weeks of gestation, participants were divided into two groups: discordant twins with an estimated fetal weight difference of more than 20% and concordant twins with a weight difference of less than 20%. Maternal complications and neonatal outcomes were compared between the two groups. Although the incidences of preeclampsia and placenta previa were significantly higher in discordant twins measured between 20 and 24 weeks, no statistical significance was found in neonatal outcomes. Delivery times were earlier, and neonatal weights were lower in discordant twins measured between 28 and 32 weeks. Neonatal outcomes such as ventilator use and neurodevelopment were also significantly different. Discordance in estimated fetal weight measured using ultrasonography between 20 and 24 weeks can be a risk factor for maternal preeclampsia and placenta previa, whereas discordance at 28-32 weeks may predict poor neonatal outcomes.Entities:
Mesh:
Year: 2022 PMID: 36050432 PMCID: PMC9437027 DOI: 10.1038/s41598-022-18864-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Comparison of maternal characteristics and pregnancy-related complications between concordant and discordant twins at 20–24 weeks of gestation in DCDA twins.
| Concordant twin | Discordant twin | ||
|---|---|---|---|
| Age (years) | 32.58 ± 4.15 | 34.18 ± 5.03 | 0.095 |
| Nulliparous, n (%) | 74 (77.89%) | 7 (63.64%) | < 0.001* |
| Prepregnant BMI (kg/m2) | 22.33 ± 3.59 | 23.02 ± 3.35 | 0.393 |
| BMI at delivery (kg/m2) | 27.62 ± 3.88 | 28.25 ± 3.45 | 0.465 |
| ART, n (%) | 67 (70.53%) | 7 (63.64%) | 0.044* |
| Preeclampsia, n (%) | 9 (9.47%) | 3 (27.27%) | 0.032* |
| GDM, n (%) | 17 (17.89%) | 0 (0.00%) | 0.063 |
| Placenta previa, n (%) | 2 (2.11%) | 2 (18.81%) | 0.002* |
| Threatened PTL, n (%) | 44 (46.32%) | 4 (36.36%) | 0.508 |
| PROM, n (%) | 4 (14.74%) | 1 (9.09%) | 0.692 |
| PPH, n (%) | 2 (2.11%) | 0 (0.00%) | 0.978 |
| Elective, n (%) | 45 (47.37%) | 5 (45.45%) | 0.533 |
| Spontaneous, n (%) | 33 (34.74%) | 3 (27.27%) | |
| Iatrogenic, n (%) | 17 (17.89%) | 3 (27.27%) | |
DCDA, dichorionic diamniotic; BMI, body mass index; ART, artificial reproductive technique; GDM, gestational diabetes mellitus; PTL, preterm labor; PROM, premature rupture of the amniotic membrane; PPH, postpartum hemorrhage.
*p values of < 0.05 are shown in bold with an asterisk (*).
Comparison of neonatal outcomes between concordant and discordant twins at 20–24 weeks of gestation in DCDA twins.
| Concordant twin | Discordant twin | ||
|---|---|---|---|
| GA at delivery (weeks) | 35.70 ± 1.63 | 35.80 ± 1.37 | 0.778 |
| Sex, male, n (%) | 111 (58.42%) | 13 (59.09%) | 1.000 |
| Birthweight (grams) | 2322.11 ± 411.26 | 2323.64 ± 500.94 | 0.987 |
| Weight discordancy at delivery, n (%) | 34 (17.89%) | 12 (54.55%) | < 0.001* |
| Apgar score at 1 min (< 7), n (%) | 26 (13.68%) | 1 (4.55%) | 0.193 |
| Apgar score at 5 min (< 7), n (%) | 0 (0.00%) | 1 (4.55%) | 0.160 |
| NICU admission, n (%) | 122 (64.21%) | 15 (68.18%) | 0.894 |
| Neonatal morbidity, n (%) | 47 (24.74%) | 1 (4.55%) | 0.061 |
| Intubation, n (%) | 9 (4.74%) | 1 (4.55%) | 0.944 |
| Ventilator use (nasal cPAP), n (%) | 59 (31.05%) | 4 (18.18%) | 0.315 |
| Oxygen supply, n (%) | 81 (42.63%) | 4 (18.18%) | 0.047* |
| Phototherapy, n (%) | 39 (20.53%) | 5 (22.73%) | 1.000 |
| Developmental delay, n (%) | 7 (3.68%) | 4 (18.18%) | 0.017* |
DCDA, dichorionic diamniotic; GA, gestational age; NICU, neonatal intensive care unit; cPAP, continuous positive airway pressure.
*p < 0.05, are shown in bold with an asterisk (*).
Comparison of maternal characteristics and pregnancy-related complications between concordant and discordant twins at 28–32 weeks of gestation in DCDA twins.
| Concordant twin | Discordant twin | ||
|---|---|---|---|
| Age (years) | 32.53 ± 4.05 | 33.94 ± 5.25 | 0.158 |
| Nulliparous, n (%) | 67 (74.44%) | 14 (87.5%) | 0.263 |
| Prepregnant BMI (kg/m2) | 22.40 ± 3.62 | 22.38 ± 3.31 | 0.976 |
| BMI at delivery (kg/m2) | 27.76 ± 3.89 | 27.23 ± 3.57 | 0.471 |
| ART, n (%) | 61 (67.78%) | 13 (81.25%) | 0.041* |
| Preeclampsia, n (%) | 8 (8.89%) | 4 (25.00%) | 0.019* |
| GDM, n (%) | 16 (17.78%) | 1 (6.25%) | 0.169 |
| Placenta previa, n (%) | 3 (3.33%) | 1 (6.25%) | 0.768 |
| Threatened PTL, n (%) | 40 (44.44%) | 8 (50.00%) | 0.697 |
| PROM, n (%) | 11 (12.22%) | 4 (25.00%) | 0.102 |
| PPH, n (%) | 2 (2.22%) | 1 (3.12%) | 1.000 |
| Elective, n (%) | 48 (53.33%) | 2 (12.50%) | < 0.001* |
| Spontaneous, n (%) | 29 (32.22%) | 7 (43.75%) | |
| Iatrogenic, n (%) | 13 (14.44%) | 7 (43.75%) | |
DCDA, dichorionic diamniotic; BMI, body mass index; ART, artificial reproductive technique; GDM, gestational diabetes mellitus; PTL, preterm labor; PROM, premature rupture of the amniotic membrane; PPH, postpartum hemorrhage.
*p values of < 0.05 are shown in bold with an asterisk (*).
Comparison of neonatal outcomes between the concordant and discordant twins at 28–32 weeks of gestation in DCDA twins.
| Concordant twin | Discordant twin | ||
|---|---|---|---|
| GA at delivery (weeks) | 35.93 ± 1.40 | 34.47 ± 2.07 | < 0.001* |
| Sex, male, n (%) | 104 (57.78%) | 20 (62.50%) | 0.760 |
| Birthweight (gram) | 2379.22 ± 370.29 | 2001.88 ± 533.51 | < 0.001* |
| Weight discordancy at delivery, n (%) | 22 (12.22%) | 24 (75.00%) | < 0.001* |
| Apgar score at 1 min (< 7), n (%) | 19 (10.56%) | 8 (25.00%) | 0.049* |
| Apgar score at 5 min (< 7), n (%) | 0 (0.00%) | 1 (3.12%) | 0.328 |
| NICU admission, n (%) | 109 (60.56%) | 28 (87.50%) | 0.006* |
| Neonatal morbidity, n (%) | 36 (20.00%) | 12 (37.50%) | 0.051 |
| Intubation, n (%) | 5 (2.78%) | 5 (15.62%) | 0.007* |
| Ventilator use (nasal cPAP), n (%) | 46 (25.56%) | 17 (53.12%) | 0.003* |
| Oxygen supply, n (%) | 65 (36.11%) | 20 (62.50%) | 0.009* |
| Phototherapy, n (%) | 30 (16.67%) | 14 (43.75%) | 0.001* |
| Developmental delay, n (%) | 4 (2.22%) | 7 (21.88%) | < 0.001* |
DCDA, dichorionic diamniotic; GA, gestational age; NICU, neonatal intensive care unit; cPAP, continuous positive airway pressure.
*p values of < 0.05 are shown in bold with an asterisk (*).
Figure 1Regression analysis of the relationship between twin discordancy and risk of maternal obstetric complications after adjustment for the confounding factors of maternal age, pre-pregnancy BMI, BMI at delivery, and gestational age at delivery. (A) Preeclampsia, (B) Placenta previa. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated, and a p value of < 0.05 was considered to be statistically significant. BMI, body mass index.
Figure 2Regression analysis of the relationship between twin discordancy and risk of neonatal outcomes after adjustment for the confounding factors of neonatal birth weight, gestational age at delivery, and NICU admission. (A) Intubation, (B) Developmental delay. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated and a p value of < 0.05 was considered to be statistically significant. NICU, neonatal intensive care unit.
Figure 3Flowchart for the review of studies. FDIU, fetal death in uterus; MCMA, monochorionic monoamniotic; MCDA, monochorionic diamniotic; TTTS, twin-to-twin transfusion syndrome; DCDA, dichorionic diamniotic.